{"nctId":"NCT02185417","briefTitle":"Diuretic Comparison Project","startDateStruct":{"date":"2016-06-15","type":"ACTUAL"},"conditions":["Hypertension"],"count":20723,"armGroups":[{"label":"Hydrochlorothiazide","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Hydrochlorothiazide (HCTZ)"]},{"label":"Chlorthalidone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Chlorthalidone (CTD)"]},{"label":"Providers","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Hydrochlorothiazide (HCTZ)","otherNames":["HCTZ"]},{"name":"Chlorthalidone (CTD)","otherNames":["CTD"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria\n\n* over age 65 years\n* receiving hydrochlorothiazide from the VA pharmacy at a daily dose of 25 or 50 mg\n* most recent SBP â‰¥120 mm Hg and no records of SBP \\<120 mm Hg in the past 90 days\n\nExclusion criteria:\n\n* impaired decision-making capacity rendering the patient unable to provide informed consent (i.e., if there is any question during the nurse's EHR chart review that the individual does not have the ability to make an autonomous decision or the PCP declines permission to randomize)\n* death expected within 6 months (inferred by PCP permission to randomize)\n* blood potassium level \\<3.1 or 3.5 (if taking digoxin) meq/L in the past 90 days\n* blood sodium level \\<130 meq/L in the past 90 days\n* enrolled in Medicare Part C (This exclusion only applied if there might be insufficient EHR data available to the study team)","healthyVolunteers":false,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time From Randomization to Composite Primary Outcome","description":"Time to study primary outcome was defined as years from randomization to the first occurrence of a composite endpoint, consisting of a nonfatal cardiovascular event or non-cancer related death. Nonfatal cardiovascular events included nonfatal myocardial infarction, stroke, hospitalization for heart failure, or urgent coronary revascularization for unstable angina. For participants who had a primary outcome, time to event was determined as the earliest admission or death date. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"1.0"},{"groupId":"OG001","value":"1.5","spread":"1.0"}]}]}]},{"type":"SECONDARY","title":"Proportion of Participants Had Nonfatal Myocardial Infarction","description":"Secondary outcomes were the individual components of the primary outcome. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"140","spread":null},{"groupId":"OG001","value":"142","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Participants Had Nonfatal Stroke","description":"Secondary outcomes were the individual components of the primary outcome. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"83","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Participants Had Hospitalization for Heart Failure","description":"Secondary outcomes were the individual components of the primary outcome. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"232","spread":null},{"groupId":"OG001","value":"242","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Participants Had Unstable Angina Leading to Urgent Coronary Revascularization","description":"Secondary outcomes were the individual components of the primary outcome. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"20","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Participants Deceased and Not Related to Cancer","description":"Secondary outcomes were the individual components of the primary outcome. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"354","spread":null},{"groupId":"OG001","value":"359","spread":null}]}]}]},{"type":"PRIMARY","title":"Proportion of Participants Had a Composite Primary Outcome","description":"The primary outcome was the first occurrence of a composite endpoint consisting of a nonfatal cardiovascular event or non-cancer related death. Nonfatal cardiovascular events included nonfatal myocardial infarction, stroke, hospitalization for heart failure, or urgent coronary revascularization for unstable angina. Time to the first event was computed based on the earliest hospital admission or death dates. Ascertainment of study outcomes was made with the use of administrative and clinical data obtained from VA EHRs through June 1, 2022, from records of Medicare claims obtained from the Centers for Medicare and Medicaid Services through 2021, and from National Death Index records through 2019. Trial outcomes were ascertained with the use of validated EHR phenotypes and, when needed, manual adjudication. Manually adjudicated outcomes were evaluated by investigators and staff who were unaware of group assignment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"675","spread":null},{"groupId":"OG001","value":"702","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1977,"n":6767},"commonTop":["Hospitalization for acute kidney injury","Hyponatremia","Hypokalemia","New onset of diabetes","Acute gout episode"]}}}